Literature DB >> 23070581

CT prediction of histological grade of hypervascular hepatocellular carcinoma: utility of the portal phase.

Akihiro Nishie1, Kengo Yoshimitsu, Daisuke Okamoto, Tsuyoshi Tajima, Yoshiki Asayama, Kousei Ishigami, Daisuke Kakihara, Tomohiro Nakayama, Yukihisa Takayama, Ken Shirabe, Nobuhiro Fujita, Hiroshi Honda.   

Abstract

PURPOSE: To elucidate whether the attenuation of hypervascular hepatocellular carcinoma (HCC) on the portal phase of dynamic CT is correlated with histological grade.
MATERIALS AND METHODS: This study group consisted of 66 patients with 74 surgically resected, hypervascular HCCs. On a preoperative dynamic study with a 64-multidetector row CT, the portal phase was scanned 60 s after injecting the contrast agent following the pre-contrast image and hepatic arterial phase. The tumor attenuation of each HCC on the portal phase was categorized into high, iso-, or low, and was compared with the predominant histological grade using Mann-Whitney's U test.
RESULTS: Twenty-nine, 29, and 16 HCCs showed high, iso-, and low attenuation on the portal phase, respectively. Tumors were classified into three well- (w-), 58 moderately (m-), or 13 poorly (p-) differentiated HCCs. The tumor attenuation of p-HCC on the portal phase was significantly lower than those of w-HCC and m-HCC (p < 0.05 and p < 0.00001).
CONCLUSION: The tumor attenuation on the portal phase may help when diagnosing the histological grade of hypervascular HCC. p-HCC are considered to show a faster contrast washout than w-HCC and m-HCC.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23070581     DOI: 10.1007/s11604-012-0149-5

Source DB:  PubMed          Journal:  Jpn J Radiol        ISSN: 1867-1071            Impact factor:   2.374


  19 in total

1.  Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies.

Authors:  H A EDMONDSON; P E STEINER
Journal:  Cancer       Date:  1954-05       Impact factor: 6.860

2.  Enhancement pattern analysis of hypervascular hepatocellular carcinoma on dynamic MR imaging with histopathological correlation: validity of portal phase imaging for predicting tumor grade.

Authors:  Daisuke Okamoto; Kengo Yoshimitsu; Akihiro Nishie; Tsuyoshi Tajima; Yoshiki Asayama; Kousei Ishigami; Masakazu Hirakawa; Yasuhiro Ushijima; Daisuke Kakihara; Tomohiro Nakayama; Yunosuke Nishihara; Shinichi Aishima; Akinobu Taketomi; Junji Kishimoto; Hiroshi Honda
Journal:  Eur J Radiol       Date:  2011-03-21       Impact factor: 3.528

3.  Imaging well-differentiated hepatocellular carcinoma with dynamic triple-phase helical computed tomography.

Authors:  C-S Li; R-C Chen; H-Y Tu; L-S Shih; T-A Zhang; J-M Lii; W-T Chen; S-J Duh; L-C Chiang
Journal:  Br J Radiol       Date:  2006-04-26       Impact factor: 3.039

Review 4.  Hepatocellular carcinoma: clinicopathological aspects.

Authors:  K Okuda
Journal:  J Gastroenterol Hepatol       Date:  1997-10       Impact factor: 4.029

5.  Impact of histological grade of hepatocellular carcinoma on the outcome of liver transplantation.

Authors:  S Tamura; T Kato; M Berho; E P Misiakos; C O'Brien; K R Reddy; J R Nery; G W Burke; E R Schiff; J Miller; A G Tzakis
Journal:  Arch Surg       Date:  2001-01

6.  Hepatocellular carcinoma: role of unenhanced and delayed phase multi-detector row helical CT in patients with cirrhosis.

Authors:  Riccardo Iannaccone; Andrea Laghi; Carlo Catalano; Plinio Rossi; Filippo Mangiapane; Takamichi Murakami; Masatoshi Hori; Francesca Piacentini; Italo Nofroni; Roberto Passariello
Journal:  Radiology       Date:  2005-02       Impact factor: 11.105

7.  Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis.

Authors:  S Jonas; W O Bechstein; T Steinmüller; M Herrmann; C Radke; T Berg; U Settmacher; P Neuhaus
Journal:  Hepatology       Date:  2001-05       Impact factor: 17.425

8.  Portal vein involvement in hepatocellular carcinoma: dynamic CT features.

Authors:  D Mathieu; P Grenier; D Lardé; N Vasile
Journal:  Radiology       Date:  1984-07       Impact factor: 11.105

9.  Triple-phase MDCT of hepatocellular carcinoma.

Authors:  K H Y Lee; M E O'Malley; M A Haider; A Hanbidge
Journal:  AJR Am J Roentgenol       Date:  2004-03       Impact factor: 3.959

10.  Multiphasic MDCT enhancement pattern of hepatocellular carcinoma smaller than 3 cm in diameter: tumor size and cellular differentiation.

Authors:  Soon Ho Yoon; Jeong Min Lee; Young Ho So; Sung Hyun Hong; Soo Jin Kim; Joon Koo Han; Byung Ihn Choi
Journal:  AJR Am J Roentgenol       Date:  2009-12       Impact factor: 3.959

View more
  7 in total

1.  Texture analysis of MR images to identify the differentiated degree in hepatocellular carcinoma: a retrospective study.

Authors:  Mengmeng Feng; Mengchao Zhang; Yuanqing Liu; Nan Jiang; Qian Meng; Jia Wang; Ziyun Yao; Wenjuan Gan; Hui Dai
Journal:  BMC Cancer       Date:  2020-06-30       Impact factor: 4.430

2.  Convolutional neural network for classifying primary liver cancer based on triple-phase CT and tumor marker information: a pilot study.

Authors:  Hirotsugu Nakai; Koji Fujimoto; Rikiya Yamashita; Toshiyuki Sato; Yuko Someya; Kojiro Taura; Hiroyoshi Isoda; Yuji Nakamoto
Journal:  Jpn J Radiol       Date:  2021-03-10       Impact factor: 2.374

3.  LI-RADS Classification and Outcomes of Hepatocellular Carcinoma Treated With Transcatheter Arterial Chemoembolization Plus Radiofrequency Ablation.

Authors:  Yuji Tachibana; Ryo Takaji; Miyuki Maruno; Koichi Honda; Mizuki Endo; Kazunari Murakami; Yoshiki Asayama
Journal:  Cancer Diagn Progn       Date:  2022-07-03

4.  The arterial tumor enhancement pattern on contrast-enhanced computed tomography is associated with primary cancer death after radiofrequency ablation for small hepatocellular carcinoma.

Authors:  Ryo Shimizu; Hideyuki Tamai; Yoshiyuki Mori; Naoki Shingaki; Shuya Maeshima; Junya Nuta; Yoshimasa Maeda; Kosaku Moribata; Yosuke Muraki; Hisanobu Deguchi; Izumi Inoue; Takao Maekita; Mikitaka Iguchi; Jun Kato; Masao Ichinose
Journal:  Hepatol Int       Date:  2015-11-03       Impact factor: 6.047

5.  Prediction of poorly differentiated hepatocellular carcinoma using contrast computed tomography.

Authors:  Kenichiro Nakachi; Hideyuki Tamai; Yoshiyuki Mori; Naoki Shingaki; Kosaku Moribata; Hisanobu Deguchi; Kazuki Ueda; Izumi Inoue; Takao Maekita; Mikitaka Iguchi; Jun Kato; Masao Ichinose
Journal:  Cancer Imaging       Date:  2014-04-22       Impact factor: 3.909

6.  Radiological appearance of hepatocellular carcinoma predicts the response to trans-arterial chemoembolization in patients undergoing liver transplantation.

Authors:  Wei Zhang; An-Hui Xu; Wei Wang; Yan-Hui Wu; Qian-Ling Sun; Chang Shu
Journal:  BMC Cancer       Date:  2019-11-05       Impact factor: 4.430

7.  Tumor attenuation and quantitative analysis of perfusion parameters derived from tri-phasic CT scans in hepatocellular carcinoma: Relationship with histological grade.

Authors:  Guodong Pang; Chunchun Shao; Yao Lv; Fang Zhao
Journal:  Medicine (Baltimore)       Date:  2021-04-23       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.